Colorectal Cancer: Determinants of Delayed Diagnosis and Its Association with Survival in Pakistani Population
DOI:
https://doi.org/10.36283/ziun-pjmd14-2/013Keywords:
cancer, Colon cancer, Rectal cancer, survival rates, prognosis, recurrence, delayed diagnosisAbstract
Background: New research indicates that Pakistan is seeing an increase in Colorectal cancer (CRC) cases among people older than 50. The main goal of this study is to find out the determinants of delayed diagnosis and its association with the survival of colorectal cancer patients in the Pakistani community.
Methods: A prospective, cohort study was conducted on biopsy-proven colorectal cancer patients, aged between 18-70 years old presenting at the surgery department of Al Tibri medical college and Hospital, Karachi from January 1st, 2023 till March 30th, 2024, with a sample size of 98 patients, follow up duration was 1 year. A purposive sampling technique was used. Statistical Package of Social Sciences (SPSS) version 22 was used to enter, sort, and analyze the data. Kaplain–Meier was generated for survival analysis for both colon and rectal carcinoma. A P-value of ≤ 0.05 was considered significant.
Results: Reasons for Delay in diagnosis were reported as misdiagnosis by a physician (OR 1.32, 0.24 – 2.16), poor knowledge of disease and symptoms (OR 2.48, 1.04 – 4.88), and herbal medication use to treat symptoms (OR 0.89, 0.047 – 1.89). Overall survival was reported as 74 (74.7%) for 1-year follow-up, however, Rectal cancer survival was 23 (23.7%) and colon cancer survival was 51 (51.3%) with a p-value of 0.365.
Conclusion: In conclusion, patients with colorectal cancer in Pakistan are often diagnosed at an advanced stage, with a dismal prognosis, due to a delay in presentation.
References
Hussain I, Majeed A, Rasool MF, Hussain M, Imran I, Ullah M, Ullah H. Knowledge, attitude, preventive practices and perceived barriers to screening about colorectal cancer among university students of newly merged district, Kpk, Pakistan–A cross-sectional study. Journal of Oncology Pharmacy Practice. 2021 Mar;27(2):359-67. https://doi.org/10.1177/1078155220922598
Miyakawa T, Kawamura H, Honda M, Takano Y, Kinuta S, Kamiga T, Yamazaki S, Muto A, Shiraso S, Yamashita N, Iwao T. Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study. PLoS One. 2022 Mar 3;17(3):e0264652.
Mezzapesa M, Losurdo G, Celiberto F, Rizzi S, d’Amati A, Piscitelli D, Ierardi E, Di Leo A. Serrated colorectal lesions: an up-to-date review from histological pattern to molecular pathogenesis. International Journal of Molecular Sciences. 2022 Apr 18;23(8):4461.
Iqbal N, Berstad P, Solbjør M, Diaz E, Czapka E, Hofvind S, Bhargava S. Access to colorectal cancer screening for Pakistani immigrants in Norway–a qualitative study. BMC Health Services Research. 2024 Dec;24(1):1-2. https://doi.org/10.1186/s12913-024-11275-7
Shamsi U, Qureshi S, Moosaji M, Azam I, Idrees R. Colorectal Cancer Survival and Its Prognostic Factors in Karachi, Pakistan. Age (years). 2024 Jun 1;50(537):54-3. doi: 10.29271/jcpsp.2024.06.688
Tufail M, Wu C. Exploring the burden of cancer in Pakistan: an analysis of 2019 data. Journal of Epidemiology and Global Health. 2023 Jun;13(2):333-43. doi.org/10.1007/s44197-023-00104-5
Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nature reviews Gastroenterology & hepatology. 2022 Aug;19(8):521-31. doi.org/10.1038/s41575-022-00612-y
Knudsen AB, Rutter CM, Peterse EF, Lietz AP, Seguin CL, Meester RG, Perdue LA, Lin JS, Siegel RL, Doria-Rose VP, Feuer EJ. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. Jama. 2021 May 18;325(19):1998-2011. doi:10.1001/jama.2021.5746
Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T, Majek O, Mužík J. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. The Lancet Oncology. 2021 Jul 1;22(7):1002-13. DOI: 10.1016/S1470-2045(21)00199-6
Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. Bmj. 2021 Sep 15;374. doi: https://doi.org/10.1136/bmj.n1855
Mascitti M, Rubini C, De Michele F, Balercia P, Girotto R, Troiano G, Muzio LL, Santarelli A. American Joint Committee on Cancer staging system 7th edition versus 8th edition: any improvement for patients with squamous cell carcinoma of the tongue?. Oral surgery, oral medicine, oral pathology and oral radiology. 2018 Nov 1;126(5):415-23.
Harber I, Zeidan D, Aslam MN. Colorectal cancer screening: impact of COVID-19 pandemic and possible consequences. Life. 2021 Nov 26;11(12):1297. https://doi.org/10.3390/life11121297
Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. The Lancet. 2011 Jan 8;377(9760):127-38. DOI: 10.1016/S0140-6736(10)62231-3
Yuan Y, Li MD, Hu HG, Dong CX, Chen JQ, Li XF, Li JJ, Shen H. Prognostic and survival analysis of 837 Chinese colorectal cancer patients. World Journal of Gastroenterology: WJG. 2013 May 5;19(17):2650. doi: 10.3748/wjg.v19.i17.2650
Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clinics in colon and rectal surgery. 2009 Nov;22(04):191-7. DOI: 10.1055/s-0029-1242458
Muhamad NA, Ma’amor NH, Rosli IA, Leman FN, Abdul Mutalip MH, Chan HK, Yusof SN, Tamin NS, Aris T, Lai NM, Abu Hassan MR. Colorectal cancer survival among Malaysia population: data from the Malaysian National Cancer Registry. Frontiers in Oncology. 2023 Nov 29;13:1132417. https://doi.org/10.3389/fonc.2023.1132417
Kelty E, Ward SV, Cadby G, McCarthy NS, O’Leary P, Moses EK, Ee HC, Preen DB. Familial and non-familial risk factors associated with colorectal cancer survival in young and middle-aged patients. International Journal of Colorectal Disease. 2019 Oct;34:1673-80. https://doi.org/10.1007/s00384-019-03380-5
Holowatyj AN, Ruterbusch JJ, Rozek LS, Cote ML, Stoffel EM. Racial/ethnic disparities in survival among patients with young-onset colorectal cancer. Journal of Clinical Oncology. 2016 Jun 20;34(18):2148-56. https://doi.org/10.1200/JCO.2015.65.0994
Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiology Biomarkers & Prevention. 2008 Aug 1;17(8):1950-62. https://doi.org/10.1158/1055-9965.EPI-07-2774
Hall C, Clarke L, Pal A, Buchwald P, Eglinton T, Wakeman C, Frizelle F. A review of the role of carcinoembryonic antigen in clinical practice. Annals of coloproctology. 2019 Dec;35(6):294. doi: 10.3393/ac.2019.11.13
Kim HR, Joo JI, Lim SW, Oh BY. Prognostic value of carcinoembryonic antigen levels before and after curative surgery in colon cancer patients. Annals of Surgical Treatment and Research. 2021 Jan;100(1):33. doi: 10.4174/astr.2021.100.1.33
Basbug M, Arikanoglu Z, Bulbuller N, Cetinkaya Z, Aygen E, Akbulut S, Satici O. Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer. Hepato Gastroenterology-Current Medical and Surgical Trends. 2011 Apr;58(106):400.
Javanparast S, Ward PR, Carter SM, Wilson CJ. Barriers to and facilitators of colorectal cancer screening in different population subgroups in Adelaide, South Australia. Medical Journal of Australia. 2012 May;196(8):521-3. https://doi.org/10.5694/mja11.10701
Segura A, Siddique SM. Reducing disparities and achieving health equity in colorectal cancer screening. Techniques and innovations in gastrointestinal endoscopy. 2023 Jan 1;25(3):284-96.
Khan AA, Macaron C, Burke CA, Singh A. Quality in Colorectal Cancer Screening. InQuality in Gastroenterology: A Concise Guide to Establishing High Value Clinical Care 2024 Aug 6 (pp. 133-153). Cham: Springer International Publishing.
Marinucci N, Moy N, Koloski N, Shah A, Austin G, Russell‐Bennett R, McGraw J, Dulleck U, Holtmann G. Social determinants and participation in fecal occult blood test based colorectal cancer screening: A qualitative systematic review and meta‐synthesis. Health Promotion Journal of Australia. 2024 Jan;35(1):9-36.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
